In this study, we demonstrated that CDC7 is highly expressed in the majority of advanced prostate cancer cell lines, patient-derived xenografts (PDXs), and adeno-CRPC and NEPC patient samples. The gene discussed is CDC7; the disease is prostate carcinoma.